Introduction
A� ��� ���� ������ p������ ����������� ����g���� ����� �� �d����, ����� �������� ���� ��� �� ����d���� �� 7 ����� �� ����� ������� ��d���d���� �1,2�. D�� �� ��� d��g ���������� ��d ��� ��g� ��k������d �� ���������� �� ����� ��g���, �� ��� � p��� p��g����� �3�. D��p��� ���������� ��������� �� ��� p������ �����, ������ 40% �� p������� ������b �� ���������� d������ �4�. I� ��� ������, ��� ������������ ���������� ��� �� ��� ����������p�, radiotherapy and surgical excision, however, the efficacy of ����� ���������� �� ������d. T� �������� ���� p��b���, �x������� studies have been performed with regard to immunotherapy, which have shown that this therapy is a significant constituent of ��� ��������� ��� ����g���� ��������� �5,6�.
T��������� �TYR� �� � ��pp��-���������g ��z��� ��d � ��p� I ���b���� p������ ���� �� �������d �� ��� g��������� �� �������, ��� ���� p�g���� �� �����b�����. TYR �� ����d�d �� ��� T�� ����� ��������� ��� ��b��� �� C ������. T�� p������ ������z�� ��� ������� ���������� �� �������� �� 3,4-d���d��x�p������������ �DOPA�, ��d ��� ���� ������z� ��� �x�d����� �� DOPA �� DOPA ������� ��d 5,6-d���d��x���d��� �� ��d���-5,6-���-���� �7,8�. TYR �� �b�� �� ������z� ��� �x������� �� �������� �� DOPA ������� d������� �9-12�. T�� TYR-������d p������ 1 �TYRP1� ����� ����d�� � 75-kD� g����p������ ���� �x��b��� �� ����� ���d �������� ������g� �� TYR �� 43% �13�. F������-more, TYRP1 has been proposed to be a second, less efficient �������� ��d��x����� �14�, ������z��g ��� g��������� �� DOPA ���� ��������. TYRP1 �� b������d �� p�������� ���b���z� ��d �������� ��� p������ ������ �� TYR �� ������ �15,16�. A� � ���k��, TYRP1 p���� � ������� ���� �� ��� �����������p� of melanoma, and it has been widely studied for a number �� ����� �17-19�. N����������, ��� ���p���� ���������� �� TYRP1 �������� ���� ��� �� b� ����������d.
T�� p������ ���d� �x�����d ��� �xp������� �� TYRP1 �� ���� ����� �� ���� ����� ��d ��� ������� p�g���� �p�������� ���� ���� �� ��� �RNA, p������ ��d ���p����g���� ������. Differential expression of TYRP1 by these UM cells was observed, providing novel insights with regard to TYRP1, which may be significant in further research and may be ������� ��� ��� d�����p���� �� ���������� ��� ��. ). RT-PCR was performed under the following conditions: 95˚C for 10 min for 1 cycle, followed by 40 cycles of denaturation at 94˚C for 30 sec, annealing at 60˚C for 30 sec and extension at 72˚C for 30 sec. Premier Primer 5 software (Premier Biosoft, Palo Alto, CA, USA) was used to assess the PCR primers. The PCR primers were as follows: TYRP1 sense, 5'-GTA ACA GCA CCG AGG ATG G-3' ��d ���������, 5'-TCC AAG CAC TGA GCG ACA T-3'; ��d g�������d���d�-3-p���p���� d���d��g����� �GAPDH� �����, 5'-TGG GGA AGG TGA AGG TCG G-3' ��d ���������, 5'-CTG GAA GAT GGT GAT GGG-3'. GAPDH was used as the internal control in PCR amplification. After staining with ethidium bromide and visualization under ultraviolet light, the amplified products were analyzed by �������p������� �� 2% �g����� g���.
Materials and methods

Cell
Quantitative (q)PCR. qPCR was performed using the aforementioned PCR program, with SYBR Premix Ex Taq II �T�k��� B��, I��.�, �� � R����-G��� 3000 R���-T��� T����� Cycler (Corbett Research, New South Wales, Australia) following the manufacturer's protocols (Takara Bio, Inc.), and the data were standardized against the quantification cycle of the GAPDH control. The extension steps were manipulated as follows: 95˚C for 30 sec for 1 cycle, followed by 95˚C for 5 sec, 60˚C for 30 sec and 72˚C for 15 sec for 40 cycles.
Western blot analysis. As previously described (21) , western blot analysis was performed to examine TYRP1 protein expression in the UM and RPE cells. Firstly, the cells were harvested, washed in cold phosphate-buffered saline (PBS) and then lysed with lysis buffer. Using the Bicinchoninic Acid Protein assay kit (Thermo Fisher Scientific Inc.), the protein samples were divided equally. In total, ~30 mg of protein extracts were generated and immunoblotting was performed according to standard protocols. Cell lysates were electrophoresed on 10% p�����������d� ���b g��� ��d ����������d �� � �������������� membrane. Immunocytochemical analysis. The collected cells were attached to glass slides, the smears of which were then fixed by 4% paraformaldehyde for 30 min and incubated with 0.1% Triton X-100 ��d 5% d������������x�d� �� PBS ��� 30 ���. S�b��-quent to being washed 3 times with cold PBS, the cells were subsequently blocked with 3% bovine serum albumin (BSA; Sigma-Aldrich) at 37˚C for 30 min. The cells were incubated with TYRP1 (rabbit anti-human polyclonal; dilution, 1:1,000; ������g ��., ��-25543; S���� C��z B����������g�, I��.,� ����b�d� overnight at 4̊C, and then subjected to the secondary antibody �g��� ����-��bb�� p���������; d�������, 1:500; ������g ��., A0545; Sigma-Aldrich) for 30 min. Following another wash in PBS for 15 min, the cells were stained with 3,3'-diaminobenzidine (Dako, Carpinteria, CA, USA). Nuclear counterstaining with Harris stain was then performed for 3 min.
Immunofluorescence staining. The cells were prepared as aforementioned, and then incubated overnight with rabbit polyclonal TYRP1 antibody at 4̊C. Subsequently, the cells were gently rinsed 3 times for 15 min each time in cold PBS, followed by incubation with goat anti-rabbit ������g��b���� G �����d��� ����b�d� �1:300 d������� �� PBS/5% BSA; Invitrogen; Thermo Fisher Scientific, Inc.) and 4',6-d����d���-2-p�������d��� �1:1,000 d������� �� PBS/5% BSA) for 10 min at 37˚C in the dark. Finally the cell smears were placed on coverslips and images were captured under a fluorescence microscope at 490-520 nm. Statistical analysis. D��� ��� p�������d �� ��� ���� ± ����d��d deviation of three independent experiments. Statistical significance was assessed using the Student's two-tailed t-test and all statistical analyses were performed using SPSS 19.0 software (SPSS Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Expression of TYRP1 in UM cells at the mRNA level. T�� present study first investigated the mRNA expression of TYRP1. Experiments were performed on four human UM cell lines �SP6.5, O�431, OC�1 ��d OC�290�, ����g ��� ����� ������� p�g���� �p�������� ���� ����, RPE, �� ��� �������. T�� RT-PCR results clearly showed that the control RPE cells did not express TYRP1, while the UM cells expressed TYRP1 mRNA, with the �x��p���� �� OC�290 ����� �P<0.01�. SP6.5 ����� �xp�����d ��� highest level of TYRP1 mRNA, while OCM1 and OM431 cells produced less in comparison (Fig. 1A) . qPCR was performed to confirm the differences in the expression of TYRP1 mRNA in these cell lines. The results were consistent with those of the RT-PCR, and showed that the SP6.5 cells expressed the highest level of TYRP1 mRNA compared with the OM431 and OCM1 ����� �P=0.015 ��d P=0.019, ���p���������.
Expression of TYRP1 in UM cells at the protein level. TYRP1
protein expression in the UM and RPE cells was determined by western blot analysis. The results were consistent with those of the PCR, and showed that the SP6.5 cells strongly expressed TYRP1, while the OCM1 and OM431 cells expressed relatively lower protein levels (P<0.01). In the RPE and OCM290 cells, TYRP1 protein expression was not found (Fig. 2) .
Expression of TYRP1 in UM cells at the cellular level. I�����-cytochemistry was used to determine the expression of TYRP1 �� ��� �� ��d RPE �����. I� ���p������ �� ��� b���k ������� group, the SP6.5, OM431 and OCM1 cells were markedly ������d �P=0.005, P=0.008 ��d P=0.032, ���p��������� �F�g. 3�, while no staining was observed in the OCM290 and RPE cells. Moreover, positive staining was found in the OCM1 and OM431 �����. T�� p������� �� TYRP1 p������ �xp������� �� ����� ����� was confirmed by immunofluorescence staining (Fig. 4) . In melanocytes, TYRP1 is significantly expressed and has been identified during melanin synthesis in the melanosome. TYRP1 is specifically expressed in melanocytes and is involved in melanin synthesis within melanosomes, as are the other members of the tyrosinase related protein family, which includes ���������� �TYR�, ��d d�p������� ����������� �TYRP2�. RPE ����� �� ����� �d���� d� ��� g������� ������� in vitro ��d�� ��d����� ������� ���d������ �22-26�. S����-T����� et al reported that TYRP1 and TYRP2 protein was not detected in cultured human RPE cells, however, this study only used a ���-������������ �������������g �����d �23�.
In the present study, it was demonstrated that the expression of TYRP1 was markedly different in four UM cell lines. Thus, ��� ������� �� �����������p� ��d����d b� ��� ����g������� �� TYRP1 in patients with UM can differ. These findings can ������� ���d �� d��������� �����d p��g�����. T�� �xp������� �� TYRP1 in the present study was as follows: TYRP1 mRNA �xp������� �� ��� OC�431 ��d OC�1 ����� �������d �� ������� levels, while expression was slightly lower in the SP6.5 cells, and almost no TYPR1 mRNA was expressed in the OCM290 cells. The TYRP1 protein level corresponded with the TYRP1 mRNA level. These findings represent the initial stages of ��d������d��g TYRP1 �xp������� �� �� �����. T�� ���������� significance and regulatory mechanisms of TYRP1 have yet to be defined, however, findings such as aforementioned may ������ �� ��� d�����p���� �� �����������p� ��� ��
